Loading…
avatar for Guru Muralimohan, PhD

Guru Muralimohan, PhD

Bayer
Senior Director, Early Pipeline Commercialization (SBU Oncology)
Guru Muralimohan is a global commercial leader with strong scientific background and broad experience in strategic marketing, new product planning, launch excellence, and market access.  At Bayer Pharmaceuticals, Guru is the global early pipeline commercial lead for the Immuno-oncology portfolio.
Prior to Bayer, Guru spent several years at Boehringer Ingelheim where he worked in Market Access, Pipeline Marketing, Strategy & Operations and Launch planning.  
Guru did a stint in management consulting where he led several projects for pharmaceutical and biotech companies on launch readiness, new product planning, search & evaluation and business development & licensing.
Guru started his career at Xcellerex Inc, a Boston based biotech company backed by venture capital firms Kleiner Perkins and VantagePoint. In that role he made significant contributions to increase shareholder value for the company which led to the eventual acquisition by GE Health Care.
Guru holds a PhD in Immunology from University of Connecticut Health Center and an MBA from University of Connecticut, School of Business.

My Speakers Sessions

Tuesday, September 20
 

9:15am EDT